111 related articles for article (PubMed ID: 16119082)
1. [The mechanisms of fucoidan action on human complement].
Galebskaia LV; Riumina EV; Bogomaz TA; Preobrazhenskaia ME
Biomed Khim; 2003; 49(6):542-7. PubMed ID: 16119082
[TBL] [Abstract][Full Text] [Related]
2. Surface-bound capsular polysaccharide of type Ia group B Streptococcus mediates C1 binding and activation of the classic complement pathway.
Levy NJ; Kasper DL
J Immunol; 1986 Jun; 136(11):4157-62. PubMed ID: 3517165
[TBL] [Abstract][Full Text] [Related]
3. [Modification of proteolytic complement cascade after treatment with exogenous heparin].
Galebskaia LV; Solovtsova IL; Riumina EV
Vopr Med Khim; 2001; 47(1):91-7. PubMed ID: 11386002
[TBL] [Abstract][Full Text] [Related]
4. An anti-complementary polysaccharide from the roots of Bupleurum chinense.
Di H; Zhang Y; Chen D
Int J Biol Macromol; 2013 Jul; 58():179-85. PubMed ID: 23570674
[TBL] [Abstract][Full Text] [Related]
5. Conformationally altered hyaluronan restricts complement classical pathway activation by binding to C1q, C1r, C1s, C2, C5 and C9, and suppresses WOX1 expression in prostate DU145 cells.
Hong Q; Kuo E; Schultz L; Boackle RJ; Chang NS
Int J Mol Med; 2007 Jan; 19(1):173-9. PubMed ID: 17143562
[TBL] [Abstract][Full Text] [Related]
6. Structure analysis of a heteropolysaccharide from Taraxacum mongolicum Hand.-Mazz. and anticomplementary activity of its sulfated derivatives.
Chen M; Wu J; Shi S; Chen Y; Wang H; Fan H; Wang S
Carbohydr Polym; 2016 Nov; 152():241-252. PubMed ID: 27516270
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the alternative pathway of complement by pH.
Fishelson Z; Horstmann RD; Müller-Eberhard HJ
J Immunol; 1987 May; 138(10):3392-5. PubMed ID: 2952717
[TBL] [Abstract][Full Text] [Related]
8. Activation of first component of complement (C1) in guinea pig serum by a polysaccharide is prevented by C1 inhibitor.
Schultz DR; Arnold PI
J Immunol; 1981 Apr; 126(4):1558-61. PubMed ID: 7204976
[TBL] [Abstract][Full Text] [Related]
9. Interaction of fucoidan with the proteins of the complement classical pathway.
Tissot B; Montdargent B; Chevolot L; Varenne A; Descroix S; Gareil P; Daniel R
Biochim Biophys Acta; 2003 Sep; 1651(1-2):5-16. PubMed ID: 14499584
[TBL] [Abstract][Full Text] [Related]
10. Complement modulating and anticoagulant effects of a sulfated exopolysaccharide released by the cyanobacterium Synechocystis aquatilis.
Volk RB; Venzke K; Blaschek W; Alban S
Planta Med; 2006 Dec; 72(15):1424-7. PubMed ID: 17051462
[TBL] [Abstract][Full Text] [Related]
11. Isolation of an anti-complementary polysaccharide from the root of Bupleurum chinense and identification of its targets in complement activation cascade.
DI HY; Zhang YY; Chen DF
Chin J Nat Med; 2013 Mar; 11(2):177-84. PubMed ID: 23787186
[TBL] [Abstract][Full Text] [Related]
12. [Synthetic inhibitors of serine proteinases. 35. Inhibition action of amidino- and guanidinophenyl derivatives against hemolysis initiated by complement activation].
Hoffmann A; Markwardt F
Pharmazie; 1989 Feb; 44(2):141-4. PubMed ID: 2748697
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of hemolytically active fluid-phase and cell-bound human C1q by an ant venom-derived polysaccharide.
Schultz DR; Loos M; Bub F; Arnold PI
J Immunol; 1980 Mar; 124(3):1251-7. PubMed ID: 7358983
[No Abstract] [Full Text] [Related]
14. Trinitrophenylated red cells (E-TNP) as a model for antibody-independent activation of the complement system via the classical pathway.
Loos M; Thesen R
J Immunol; 1978 Jul; 121(1):24-8. PubMed ID: 670702
[TBL] [Abstract][Full Text] [Related]
15. Structure of a homofructosan from Saussurea costus and anti-complementary activity of its sulfated derivatives.
Fan H; Liu F; Bligh SW; Shi S; Wang S
Carbohydr Polym; 2014 May; 105():152-60. PubMed ID: 24708964
[TBL] [Abstract][Full Text] [Related]
16. Complement modulating activity of Rwandan medicinal plants.
Cos P; Hermans N; Van Poel B; De Bruyne T; Apers S; Sindambiwe JB; Vanden Berghe D; Pieters L; Vlietinck AJ
Phytomedicine; 2002 Jan; 9(1):56-61. PubMed ID: 11924765
[TBL] [Abstract][Full Text] [Related]
17. Sphingomyelinases D induce direct association of C1q to the erythrocyte membrane causing complement mediated autologous haemolysis.
Tambourgi DV; Pedrosa MF; de Andrade RM; Billington SJ; Griffiths M; van den Berg CW
Mol Immunol; 2007 Jan; 44(4):576-82. PubMed ID: 16540172
[TBL] [Abstract][Full Text] [Related]
18. Serglycin inhibits the classical and lectin pathways of complement via its glycosaminoglycan chains: implications for multiple myeloma.
Skliris A; Happonen KE; Terpos E; Labropoulou V; Børset M; Heinegård D; Blom AM; Theocharis AD
Eur J Immunol; 2011 Feb; 41(2):437-49. PubMed ID: 21268013
[TBL] [Abstract][Full Text] [Related]
19. Modulation of human endothelial cell proliferation and migration by fucoidan and heparin.
Giraux JL; Matou S; Bros A; Tapon-Bretaudière J; Letourneur D; Fischer AM
Eur J Cell Biol; 1998 Dec; 77(4):352-9. PubMed ID: 9930660
[TBL] [Abstract][Full Text] [Related]
20. [Sulfated polysaccharides as inhibitors of receptor activity of P-selectin and P-selectin-dependent inflammation].
Semenov AV; Mazurov AV; Preobrazhenskaia ME; Ushakova NA; Mikhaĭlov VI; Berman AE; Usov AI; Nifant'ev NE; Bovin NV
Vopr Med Khim; 1998; 44(2):135-44. PubMed ID: 9634715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
